US Patent Issued on July 28 for "In vitro method for the prognosis of patients suffering from HER2-positive breast cancer" (Italian, Spanish Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,549, issued on July 28.

"In vitro method for the prognosis of patients suffering from HER2-positive breast cancer" was invented by Aleix Prat Aparicio (Barcelona, Spain), Laia Pare Brunet (Barcelona, Spain), Pierfranco Conte (Pisa, Italy), Maria Vittoria Dieci (Padua, Italy) and Valentina Guarneri (Padua, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention refers to an in vitro method for the prognosis of patients suffering from HER2+ breast cancer and/or for the prediction of response to anti-HER2 therapies in patients suffering from HER2+ breast cancer."

The patent was filed on July 26, 2021, under Application No. 18/018,29...